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ABSTRACT
Introduction: Laparoscopic hysterectomy for large fi-
broid uteri is technically a difficult procedure. In this
article, we report our experience with fibroid uteri 1k g
in weight.
Materials and Methods: An intent-to-treat study.
Results: From 2003 to 2009, 13 patients were successfully
treated for large fibroid uteri with postoperative speci-
mens weighing 1000 g. Four patients had total abdom-
inal hysterectomy, one patient had laparoscopically as-
sisted vaginal hysterectomy, and 8 patients had total
laparoscopic hysterectomy. The last 6 cases were total
laparoscopic hysterectomy cases.
Conclusion: With experience and specialized tech-
niques, total laparoscopic hysterectomy can replace ab-
dominal hysterectomy for large uteri.
Key Words: Large fibroid uterus, Total laparoscopic hys-
terectomy, Total abdominal hysterectomy, Laparoscopi-
cally assisted vaginal hysterectomy, Morcellation, Bowel
bag.
INTRODUCTION
Fibroids (leiomyomata uteri) are a common gynecological
pathology and the leading indication for hysterectomy in the
United States. Between 25% to 50% of reproductive age
women complain of fibroids, and additionally 80% of surgi-
cal specimens and autopsies show microscopic evidence of
fibroids.1 Uterine fibroids are more common in African-
American women with a tendency towards earlier and more
severe disease.2–4 Age-standardized rates of ultrasound- or
hysterectomy-confirmed diagnoses per 1000 woman-years
are estimated at around 8.9 among white women and 30.6
among black women.3 The prevalence of uterine fibroids is
approximately 60% among African-American women by age
35 and increases to over 80% by age 50. Caucasian women
have a prevalence of 40% by age 35, and the prevalence rises
to 70% by age 50.4 Uterine fibroid tumors consume a signif-
icant amount of healthcare resources in the United States.
More than $2 billion are spent every year on hospitalization
costs for uterine fibroids, mainly on inpatient care, particu-
larly, hysterectomy.5 Healthcare costs are more than $4600
per woman per year.6 In addition, uterine fibroids are asso-
ciated with high disability costs, due to the long recovery
period after abdominal and vaginal hysterectomies. We think
that the real cost in lost workdays, lost corporate productiv-
ity, cost of disability income to corporate sponsors, loss of
personal disposable wealth, and the increase in patient suf-
fering and physical pain is considerably higher.
Leiomyomas may grow to a large volume in neglected
cases. In the literature, there are a few autopsy reports of
huge leiomyomas weighing up to 23 kg that compressed
the lungs, causing severe congestion.7 Such cases may still
happen but occur mostly in developing countries. They
may rarely be encountered in developed countries, such
as the case reported recently by Nappi et al8 in Italy. He
described a bilobated giant myoma of the uterus that
weighed 27.7 kg. Such cases are, obviously, only treated
with abdominal hysterectomy. Large uteri of much smaller
size (5000 g) can cause serious complications including
deep venous thrombosis (DVT) due to blood stasis in the
pelvic venous plexus.9
In a previous article,10 we described a 3043 g fibroid
uterus removed by total laparoscopic hysterectomy with
in situ morcellation. In the current article, we expand on
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SCIENTIFIC PAPERthat previous article and report our experience with fi-
broid uteri 1 kg in mass, including their routes of treat-
ment, intraoperative difficulties, and postoperative com-
plications.
MATERIALS AND METHODS
We retrospectively reviewed the charts of patients from
our suburban gynecological practice, Heart of Georgia
Women’s Center, who were treated with hysterectomy
and yielded uteri 1000 g in weight. These patients were
part of a larger database of patients treated by a single
operator–Dr. Heaton. After acquiring the necessary lapa-
roscopic skills, he intended to do all hysterectomies via
the total laparoscopic route, if feasible. For the database
the following variables were collected: age, gravida/para
status, body mass index (BMI), history of cesarean deliv-
ery, uterus size, type of surgery, specimen weight, blood
transfusion, reason for readmission, if any, and other data
points not relevant to this article. All patients had negative
Pap smears and endometrial biopsies and were counseled
on the risks and benefits of laparoscopic surgery before
the operation was performed. In cases where suspicious
fibroids could harbor a malignancy, patients were coun-
seled about their increased risk of a hidden leiomyosar-
coma, and the surgery was performed by the total abdom-
inal route in some of these patients early in the study.
Dr. Heaton developed the bowel bag technique for pelvic
mass isolation, which has been explained in detail else-
where.11 According to his method, after the hysterectomy
is completed extrafascially, with the uterus intact, a bowel
bag is inserted into the abdomen via the vagina, and the
uterus is maneuvered into it. The mouth of the bag is then
brought out through the vagina, and the uterus is morcel-
lated vaginally with retractors placed inside the bag in the
vagina in the same manner as they would be placed for a
vaginal hysterectomy. This prevents intraabdominal con-
tamination with a potentially malignant mass.
RESULTS
From 2003 to 2009, 13 patients were treated for large uteri
with postoperative specimens weighing 1000 g. Of
these, 4 patients were treated by total abdominal hyster-
ectomy (TAH), 1 had laparoscopically assisted vaginal
hysterectomy (LAVH), and 8 underwent total laparoscopic
hysterectomy (TLH).
The patients’ data are presented in Table 1. It is evident
from this table that in the last years we were able to
Table 1.
Summary of the 13 Cases of Fibroid Uteri 1000 g
Year Age GP* BMI* H/O
C-S*
Uterus Size
(weeks)
Type of Surgery
& Morcellator
Diameter
Intraoperative
Incidents
Operative
Time
(minutes)
Blood
Loss
(mL)
Resected
Weight
(grams)
2003 48 G2P2 46 2 18–20 TAH 80 100 1109
2003 51 G4P4 35 0 14 TAH 108 350 1007
2004 48 G3P3 53 1 12–14 LAVH 20 mm Bladder Injury 296 1000 1064
2006 36 G3P2 52 0 16 TAH 120 600 1219
2006 47 G1P1 33 0 24 TLH 15 mm 357 800 3043
2007 40 G5P5 50 0 18–20 TLH 20 mm 182 350 1210
2007 38 G0P0 32 0 28–30 TAH 86 250 2669
2007 54 G3P3 35 0 16 TLH 20 mm 175 100 1446
2007 40 G2P1 23 0 18–20 TLH 20 mm 200 150 1105
2008 39 G2P2 31 0 16 TLH BB 190 150 1006
2009 36 G1P1 27 0 28 TLH BB 330 400 1859
2009 49 G1P1 26 0 14 TLH BB 185 50 1035
2009 41 G3P3 42 0 24 TLH 20 mm 140 125 1484
*GPgravida para; BMIbody mass index; H/O C-Shistory of Cesarean section; BBBowel Bag; TAHtotal abdominal hysterec-
tomy; LAVHlaparoscopic assisted vaginal hysterectomy; TLHtotal laparoscopic hysterctomy.
JSLS (2010)14:178–182 179gradually replace TAH with TLH for large uteri with no
significant complications. The last 6 patients were total
laparoscopic hysterectomy cases with no complications.
Operative time and blood loss correlated with the mass of
the resected uterus in TLH cases (Figures 1 and 2).
The largest uterus was 24-week size, 3043 g, removed by
total laparoscopic hysterectomy with in situ morcellation
in 5 hours 57 minutes with a blood loss of 800 mL.10 This
was the only patient who required readmission 3 days
after discharge. The patient came back with nausea, vom-
iting, and abdominal distension despite flatus and good
bowel sounds. She was treated with antibiotics for pelvic
cellulitis and was discharged home on the third day in
good condition.
DISCUSSION
Hysterectomy has many positive attributes as a treatment
for fibroids. Because the entire uterus is removed, the
possibility of new fibroids growing back is eliminated.
Menstrual bleeding is stopped permanently and recurrent
menorrhagia cannot occur. The risks of cervical, uterine,
endometrial, and if combined with bilateral salpingo-
oophorectomy, ovarian cancer are eliminated. The likeli-
hood of repeated gynecological surgery is greatly re-
duced. We have done numerous hysterectomies either for
recurrent fibroids or pain, or both, resulting from severe
adhesions caused by prior myomectomies and a smaller
number for chronic pelvic pain and adhesions following
uterine artery embolization procedures. We believe that
laparoscopic hysterectomy is the preferred surgery for
patients who do not desire further childbearing to obviate
the need for repeat surgeries and because in most cases
large uteri are secondary to multiple fibroids. Uterus-
sparing treatment with laparoscopic myomectomy for
these patients would be a more technically challenging
operation without significant long-term benefits, except
for the preservation of future childbearing function, which
most of these patients do not desire to keep. In no way
does laparoscopic myomectomy compare favorably with
laparoscopic hysterectomy: bleeding can still be heavy,
severe adhesions may ensue and cause infertility and
pain, and new fibroids may grow that may be malignant.12
It is doubtful that uterine artery embolization or any other
in situ destructive procedures would survive a careful
cost-benefit risk analysis compared with laparoscopic hys-
terectomy that causes much fewer adhesions,13 ends the
risk of recurrent fibroids, cervical cancer, endometrial
cancer, sarcoma, and ovarian cancer, if concomitant bilat-
eral salpingo-oophorectomy is performed.
Laparoscopic hysterectomy also has the advantage of less
pain. In our opinion, the low level of discomfort from
laparoscopic hysterectomy in the short term is comparable
to that after embolization, but in the long term it is better.
Most of these patients are able to go home within 24 hours
of surgery, and if they have a sedentary job are able to
return to work in one week. They have far less pain,
shorter hospital stay, fewer wound complications (actu-
ally there are no significant wounds to become infected),
fewer pulmonary complications, and faster recovery than
in abdominal hysterectomy patients. In our patient cohort,
2 of the abdominal hysterectomies had wound problems,
a 50% incidence. It is noteworthy that 10 patients were
obese (BMI30), and 2 were overweight (BMI25),
which is consistent with a previous study that reported an
increased risk of wound healing complications in obese
patients.14
In cases of large uteri, pretreatment with a gonadotropin-
releasing hormone (GnRH) agonist may be necessary to
induce uterine tissue shrinkage and decrease vascularity.
Devascularization of the uterus at the start of hysterec-
Figure 1. Operative time and resected mass correlation (TLH
cases only).
Figure 2. Estimated blood loss and resected mass correlation
(TLH cases only).
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blood loss. The blood supply to the uterus should prefer-
ably be controlled before morcellation of an enlarged
uterus. Sometimes, the injection of dilute vasopressin so-
lution around the largest myoma before morcellation is
begun may help control capillary bleeding, making it
easier to identify larger vessels for coagulation with bipo-
lar cautery and keeping the field dry to maintain good
exposure. Occasionally, starting morcellation of a large
myoma before its vasculature is totally controlled is the
only way to gain enough exposure to complete the hys-
terectomy. Most intraoperative conversions to laparotomy
occur because of intraoperative bleeding or concern
about uncontrolled bleeding when the vascular pedicles
cannot be controlled. Experienced laparoscopists usually
have a low conversion rate from laparoscopy to laparot-
omy, around 2% to 4%.15,16
Most large fibroid uteri are actually not particularly diffi-
cult cases in experienced hands, just tedious with a lot of
time spent with repetitive morcellation. It is important to
use a 20-mm or 25-mm morcellator for large myomas, if
available. From our experience, the ideal morcellator for
very large uteri should have a wide cannula diameter with
relatively high revolutions per minute (rpm) for smooth
cutting and good lower-end torque to prevent bogging
down and overheating when going through dense myoma
tissue. It should have an ergonomic handle with an incor-
porated trigger bar that runs parallel to the handle to allow
for easy activation over time without tiring the operator’s
hands (instead of the foot or thumb activation). It should
also allow for full pull through of the tissue so that the
morcellator does not need to be removed and reinserted
during the morcellation process, and it should have a
retractable V-shaped guide to keep the morcellator skim-
ming over the uterus rather than penetrating it. The guide
should insert with the cutting cannula and not be integral
with the trocar, because the morcellator V-shaped tissue
guides integral to the trocar are not particularly useful with
in situ morcellation of very large uteri because the cannula
requires insertion well beyond the limits of the trocar.
With large sized uteri, upper quadrant punctures are
needed for visualization and proper traction angles with
instruments. Exposure of the vascular pedicles can be
greatly enhanced by using gravity as a retractor, leaning
the patient to the right when working on the left infun-
dibulopelvic ligament and uterine vessels and then to the
left when working on the right side. There is no reason
not to incorporate facilitating myomectomy when needed
to allow better access to the vascular pedicles or to allow
disimpaction of the impacted fibroid uterus from the pel-
vis so that the vascular pedicles can be reached.
Changing the camera angle by using lateral punctures
and, if needed, using a 35° cystoscope as laparoscope can
facilitate seeing around protruding fibroids so that impor-
tant structures and vascular pedicles can be visualized and
dealt with. We find the most challenging fibroid tumors to
be those associated with severe adhesions or an obliter-
ated cul-de-sac from endometriosis. Adhesions have to be
lysed prior to beginning the hysterectomy to allow ade-
quate exposure for safe surgery. In the case of a large
fibroid uterus with an obliterated cul-de-sac, it may be
useful to first do myomectomy on the largest central fi-
broid to allow better exposure and traction of the lateral
and posterior uterine wall so that the ureter can be located
at the pelvic brim. The ureter can then be followed to the
cardinal web (the infundibulopelvic ligament is taken as
soon as the ureter is separated from it if the ovary is to be
taken), and the uterine vessel can usually be easily found
at this level coming off the hypogastric artery (internal
iliac artery) lateral to the ureter and clipped.17 An alterna-
tive anterior approach has been described utilizing retro-
grade tracking of the umbilical ligament (RUL).18,19 Once
the vascular pedicles are controlled, careful uterine reduc-
tion will allow the remaining dissection of the posterior
cul-de-sac.
CONCLUSION
Total laparoscopic hysterectomy can replace abdominal hys-
terectomy for large uteri if the surgeon has additional skills
and uses specialized techniques beyond those necessary for
the majority of total laparoscopic hysterectomies. It should
be noted, however, that suspicious fibroids growing in
menopausal women, growing on leuprolide or other GNRH
agonists, rapidly growing over a short time frame in pre-
menopausal women, exceeding 10 cm in diameter, or that
appear visibly suspicious must be treated with prudence
because of the rare possibility of a leiomyosarcoma.
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